Man Group plc - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$189,172
-3.1%
143,312
+10.1%
0.00%0.0%
Q4 2022$195,168
+550.6%
130,112
+411.1%
0.00%
Q3 2022$30,000
+42.9%
25,456
+131.4%
0.00%
Q3 2019$21,000
-83.2%
11,000
-75.0%
0.00%
-100.0%
Q2 2018$125,00044,0000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders